Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Study to Assess the Safety and Immunogenicity of an IM Influenza Vaccine (Multimeric-001) Followed by Administration of TIV to Elderly Volunteers
This study is currently recruiting participants.
Verified August 2011
by BiondVax Pharmaceuticals ltd.
Study NCT01419925 Information provided by BiondVax Pharmaceuticals ltd.
First Received on August 17, 2011. No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Interventions listed in this trial
Multimeric-001, 500 mcg
Saline and TIV
Sponsors listed in this trial
BiondVax Pharmaceuticals ltd.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers